Trials / Completed
CompletedNCT00486473
Multihance Versus Magnevist in Breast MRI
Phase III Multicenter Double-Blind, Randomized, Crossover Study to Compare MultiHance With Magnevist in Contrast-enhanced Magnetic Resonance Imaging (MRI) of the Breast
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Bracco Diagnostics, Inc · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To show if one MRI contrast agent is better than another one in the diagnosis of malignant breast lesions compared to histopathology
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Multihance | 0.5 Molar at a single dose injection |
| DRUG | Magnevist | 0.5M at a single dose injection |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2007-06-14
- Last updated
- 2010-07-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00486473. Inclusion in this directory is not an endorsement.